-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RBM-007 in Wet (Neovascular / Exudative) Macular Degeneration
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. RBM-007 in Wet (Neovascular / Exudative) Macular Degeneration Drug Details: RBM-007 is under development...
-
Product Insights
California RBM – 2107-2121 Westwood Boulevard Residential Development – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our California RBM - 2107-2121 Westwood Boulevard Residential Development - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RBM-007
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry RBM-007 Drug Details RBM-007 is under development for the treatment of lung cancer, achondroplasia,...
-
Product Insights
Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Alzheimer is a progressive neurologic disorder beginning with mild memory loss. It could possibly lead to a loss of the ability to carry on a conversation and respond to the environment. The Alzheimer pipeline market research report provides comprehensive information about the Alzheimer pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Basic fibroblast growth factor also known as bFGF or FGF2 is a member of the fibroblast growth factor family. This protein plays an important role in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The Fibroblast Growth Factor 2 pipeline drugs market research report provides comprehensive information on the therapeutics under development for Fibroblast Growth Factor 2, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration...
-
Product Insights
Achondroplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Achondroplasia pipeline market research report provides comprehensive information on the therapeutics under development for Achondroplasia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Achondroplasia and features dormant and discontinued projects.
-
Product Insights
Beta Nerve Growth Factor (Beta NGF or NGF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The nerve growth factor is a neurotrophic factor involved in the regulation of growth, maintenance, proliferation, and survival of certain target neurons. It inhibits metalloproteinase-dependent proteolysis of platelet glycoprotein VI. The beta nerve growth factor drugs in development market report provides an in-depth analysis of Beta NGF or NGF targeted pipeline therapeutics. The report provides comprehensive information on the Beta Nerve Growth Factor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration...
-
Product Insights
Beta Nerve Growth Factor (Beta NGF or NGF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update
Beta Nerve Growth Factor (Beta NGF or NGF) pipeline Target constitutes close to 11 molecules. The latest report Beta Nerve Growth Factor - Drugs in Development, 2021, outlays comprehensive information on the Beta Nerve Growth Factor (Beta NGF or NGF) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. Beta Nerve Growth Factor (Beta NGF or NGF) - Nerve growth factor is a neurotrophic factor involved in the...